Skip to main content
Arati V. Rao, MD, Oncology, Durham, NC

Arati V. Rao MD


Associate Professor, Medicine, Duke University School of Medicine

Join to view full profile
  • 111g Durham VA Medical Ctr508 Fulton StDurham, NC 27710

  • Phone+1 919-286-6944

  • Fax+1 919-286-6896

Dr. Rao is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a board certified, dual fellowship trained, geriatric-oncologist. I specialize in the care of elderly patients with hematologic malignancy, in particular Acute Myeloid Leukemia.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003
  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2000 - 2002
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1998 - 2000
  • University of Rochester Medical Center
    University of Rochester Medical CenterInternship, Internal Medicine, 1997 - 1998
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 1996

Certifications & Licensure

  • NC State Medical License
    NC State Medical License Current

Awards, Honors, & Recognition

  • Travel award for junior faculty IACRLRD Meeting, 2009
  • Wendell Rosse M.D. Teaching Award Duke University Medical Center Hematology-Oncology Fellows for Excellence in Teaching, 2007
  • Merit Award American Society of Clinical Oncology, 2002

Publications & Presentations

PubMed

Journal Articles

  • Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia  
    Morris TA, DeCastro CM, Diehl LF, Gockerman JP, Lagoo AS, Li Z, Moore JO, Rizzieri DA, Rao AV, Leukemia Research, 1/1/2013
  • Phase I Study of Dose Dense Induction and Consolidation with Gemtuzumab Ozogamicin and High Dose Cytarabine in Older Adults with AML  
    Rao AV, Rizzieri DA, DeCastro CM, Diehl LF, Lagoo AS, Moore JO, Gockerman JP, Journal of Geriatric Oncology, 1/1/2012
  • Role of pain medications, consultants, and other services in the improved pain control of elderly cancer patients in the geriatric evaluation and management units (GEM...  
    Nipp R, Sloane R, Rao AV, Schmader K, Cohen HJ, Journal of the American Geriatrics Society, 1/1/2012

Abstracts/Posters

  • KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase...
    Arati V. Rao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • With Summit Leading the Pack in PD-1xVEGF Bispecifics, Pfizer Lays Out Its Own Plan to Replace Keytruda
    With Summit Leading the Pack in PD-1xVEGF Bispecifics, Pfizer Lays Out Its Own Plan to Replace KeytrudaNovember 11th, 2025

Grant Support

  • NIH Clinical Oncology Research Career Development Program.National Institute of Aging2012–2014
  • NIH Clinical Oncology Research K12 Career Development Program.National Institute of Health (NIH)2009–2011

Professional Memberships

Other Languages

  • Hindi, French, Marathi, Kannada, Gujarati

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: